Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Rosa Maria R. Pereira
A Randomized Trial of Zoledronic Acid to Prevent Bone Loss in the First Year After Kidney Transplantation
Journal of the American Society of Nephrology : JASN
Medicine
Nephrology
Bioimpedance Underestimates Bone Mineral Content in Association With High Levels of Phosphate
Journal of Renal Nutrition
Medicine
Nutrition
Dietetics
Nephrology
Related publications
Acetylsalicylic Acid Does Not Prevent First Trimester Unexplained Recurrent Pregnancy Loss: A Randomized Controlled Trial
Acta Obstetricia et Gynecologica Scandinavica
Medicine
Gynecology
Obstetrics
Changes in Bone Histomorphometry After Kidney Transplantation
Clinical Journal of the American Society of Nephrology
Epidemiology
Nephrology
Critical Care
Transplantation
Intensive Care Medicine
A Randomised Controlled Trial of Azithromycin to Prevent Chronic Rejection After Lung Transplantation
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
Biochemical Characteristics of Bone Mineral Metabolism Before and Throughout the First Year After Kidney Transplantation, Persistent Hyperparathyroidism, and Risk Factors in a Latin Population
International Journal of Endocrinology
Endocrine
Endocrinology
Metabolism
Autonomic Systems
Diabetes
Treatment With Vitamin D and Calcium Reduces Bone Loss After Renal Transplantation: A Randomized Study
Journal of the American Society of Nephrology : JASN
Medicine
Nephrology
Electrocardiographic Abnormalities in the First Year After Heart Transplantation
Journal of Electrocardiology
Cardiovascular Medicine
Cardiology
Effects of Zoledronic Acid on Bone Fusion in Osteoporotic Patients After Lumbar Fusion
Osteoporosis International
Medicine
Endocrinology
Metabolism
Diabetes
Indirect Evaluation of Bone Saturation With Zoledronic Acid After Long‐Term Dosing
Oncologist
Cancer Research
Medicine
Oncology
The Zodiak Trial: Protocol of a Double-Blind, Placebo-Controled, Two-Year Clinical Trial of Zoledronic Acid as a Disease-Modifying Drug in Knee Osteoarthritis With Bone Marrow Lesions
Osteoarthritis and Cartilage
Sports Medicine
Rheumatology
Orthopedics
Biomedical Engineering
